… the pharmacokinetic parameters between these two groups. … In this study, both
pharmacokinetics and pharmacodynamics (… with NIDDM and healthy subjects, male and female …

… between plasma exposure to LSD and the pharmacodynamic effects at corresponding times…
in 24 and 16 healthy subjects, respectively. The pharmacokinetic data and concentration–…

… This study examined the pharmacokinetics and pharmacodynamics of lignocaine and
MEGX in eight healthy male volunteers given lignocaine HCl 120mg, MEGX HCl 120 mg, …

… healthy, young male subjects and to assess the intra‐ and inter‐subject variability of ASA
pharmacokinetics … Ten subjects each received a single, open‐label, oral 80‐mg ASA dose on …

… assessed the pharmacokinetics and pharmacodynamics of two … of healthy subjects. The
study showed first-order elimination for two different moderate doses of GHB in healthy subjects, …

The safety, pharmacokinetics, and pharmacodynamics of single and multiple doses of the
angiotensin II (AII) AT 1 blocker irbesartan were assessed in healthy subjects. In this single‐…

… Here we report the favorable findings of the first Phase I clinical trials of AZD3293 in healthy
subjects and patients with mild to moderate Alzheimer’s disease. AZD3293 was given as an …

… We evaluated the safety, tolerability, pharmacokinetics, and preliminary pharmacodynamics
… to young healthy male subjects. We also evaluated the pharmacokinetics of CHF5074 in …

Aim The aim of this study was to investigate the effect of St John's wort and ginseng on the
pharmacokinetics and pharmacodynamics of warfarin. Methods This was an open‐label, three…

… Moreover, the absence of an effect of sitagliptin on glycemic parameters in healthy
subjects in this study, together with the observed lack of effect on signs and symptoms of …